AAV9-mediated gene therapy in a knock-in mouse model of infantile neuroaxonal dystrophy

被引：0
|
作者：
Whaler, S. [1 ]
Geard, A. F. [1 ]
Poupon-Bejuit, L. [1 ]
Massaro, G. [1 ]
Hughes, M. P. [1 ]
Lalji, K. [1 ]
Waddington, S. N. [1 ,2 ]
Kurian, M. A. [1 ,3 ]
Rahim, A. A. [1 ]
机构：
[1] UCL, London, England
[2] Univ Witwatersrand, Johannesburg, South Africa
[3] Great Ormond St Hosp Sick Children, London, England
来源：
HUMAN GENE THERAPY | 2022年 / 33卷 / 23-24期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
OR30
引用
收藏
页码：A12 / A12
页数：1
相关论文
共 50 条
  • [1] AAV9-Mediated Gene Therapy in a Knock-In Mouse Model of Infantile Neuroaxonal Dystrophy
    Geard, Amy F.
    Whaler, Sammie
    Liu, Wenfei
    Massaro, Giulia
    Hughes, Michael
    Nelvagal, Hemanth
    Poupon-Bejuit, Laura
    Albutt, Jessica
    Lalji, Krushni
    Waddington, Simon
    Kurian, Manju
    Rahim, Ahad A.
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 342 - 342
  • [2] Correction of visual and auditory function by AAV9-mediated gene therapy in a mouse model of mucopolysaccharidosis type IIIB
    Ribera, A.
    Motas, S.
    Ramirez, L.
    Marco, S.
    Sanchez, V.
    Sanchez, X.
    Bertolin, J.
    Perez, J. A.
    Leon, X.
    Varela-Nieto, I.
    de la Villa, P.
    Haurigot, V.
    Bosch, F.
    [J]. HUMAN GENE THERAPY, 2017, 28 (12) : A67 - A67
  • [3] Correction of Visual and Auditory Function by AAV9-Mediated Gene Therapy in a Mouse Model of Mucopolysaccharidosis Type IIIB
    Ribera, Albert
    Motas, Sandra
    Ramirez, Laura
    Marco, Sara
    Sanchez, Victor
    Sanchez, Xavier
    Bertolin, Joan
    Perez, Jennifer A.
    Leon, Xavier
    Varela-Nieto, Isablel
    de la Villa, Pedro
    Haurigot, Virginia
    Bosch, Fatima
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 114 - 114
  • [4] AAV9-MEDIATED GENE THERAPY OF CHOLINE ACETYLTRANSFERASE DEFICIENT MICE
    Thomas, Clementine A. D.
    Lin, Cameron C.
    Huynh, Thanh L.
    Wei, David T.
    Vazquez, Jessica
    Maselli, Ricardo A.
    [J]. MUSCLE & NERVE, 2022, 65 : S22 - S23
  • [5] A novel mouse model of infantile neuroaxonal dystrophy.
    Parker, SM
    Bouley, DM
    McIntire, JJ
    Hadar, E
    Coryell, RJ
    Ching, KHL
    Hayflick, SJ
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 520 - 520
  • [6] Development of an AAV9-mediated gene therapy for hereditary spastic paraplegia 47
    Scarrott, J. M.
    Coldicott, I.
    Davies, A.
    Hirst, J.
    Karyka, E.
    Bauer, C.
    Azzouz, M.
    [J]. HUMAN GENE THERAPY, 2019, 30 (08) : A18 - A18
  • [7] Efficient AAV9-mediated gene delivery to the heart
    Liao Haihan
    Tang, Qizhu
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C18 - C18
  • [8] AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy
    Alexia Kagiava
    Christos Karaiskos
    Jan Richter
    Christina Tryfonos
    Matthew J. Jennings
    Amanda J. Heslegrave
    Irene Sargiannidou
    Marina Stavrou
    Henrik Zetterberg
    Mary M. Reilly
    Christina Christodoulou
    Rita Horvath
    Kleopas A. Kleopa
    [J]. Gene Therapy, 2021, 28 : 659 - 675
  • [9] AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy
    Kagiava, Alexia
    Karaiskos, Christos
    Richter, Jan
    Tryfonos, Christina
    Jennings, Matthew J.
    Heslegrave, Amanda J.
    Sargiannidou, Irene
    Stavrou, Marina
    Zetterberg, Henrik
    Reilly, Mary M.
    Christodoulou, Christina
    Horvath, Rita
    Kleopa, Kleopas A.
    [J]. GENE THERAPY, 2021, 28 (10-11) : 659 - 675
  • [10] AAV9-mediated EPO gene delivery in a rat model of Parkinson's disease
    Duan, Wei-Ming
    Yang, Chun
    Xue, Yue-Qiang
    Klein, Ronald L.
    Zhao, Li-Ru
    [J]. NEUROREPORT, 2014, 25 (03) : 141 - 141
12345